Ihsane SKITIOUI

Dr. Ihsane SKITIOUI

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2026 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Open access
PDF file
ISIhsane SKITIOUI
Ihsane SKITIOUI
KNKarima Nouni
Karima Nouni
SISalma Ichou
Salma Ichou
RLRachida Laraichi
Rachida Laraichi
ALAmine Lachgar
Amine Lachgar
KHKhalid Hassouni
Khalid Hassouni
Background: Erectile dysfunction (ED) is a frequent and impactful side effect of prostate cancer radiotherapy. Data on the relationship between radiation dose to the penile bulb (PB) and ED severity in North African populations remain limited. This study aimed to assess ED prevalence and severity in Moroccan men treated with volumetric modulated arc therapy (VMAT) and identify associated clinical and dosimetric predictors. Materials and methods: A retrospective analysis was performed on 52 Moroccan patients treated with VMAT for localized or locally advanced prostate cancer (2021–2024). Erectile function was evaluated using the Sexual Health Inventory for Men (SHIM) score. Analyzed dosimetric variables included PB mean dose, PB V30, PB V50, PB V60, and doses to 25–90% of the PB volume (PB D25, PB D50, PB D75, PB D90). Statistical methods included ANOVA, Pearson correlation, ROC curve analysis, and multivariate logistic regression. Results: Moderate to severe ED was found in 84.6% of patients. Strongest correlations with SHIM score were seen for PB D25 (r = –0.47), PB mean dose (r = –0.45), PB V30 (r = –0.41), and PB D50 (r = –0.41). ROC analysis identified PB V30 > 64.9% and PB D50 > 38.7 Gy as optimal cutoffs for predicting ED. ISUP grade was significantly associated with ED severity (p = 0.007), while TNM stage and D’Amico classification were not. No significant association was observed with hypertension, diabetes, or smoking. Conclusions: This study highlights the importance of PB dosimetry in predicting post-radiotherapy ED. PB V30 and PB D50 emerged as reliable predictors, underscoring the need to integrate PB constraints in VMAT planning to preserve erectile function in prostate cancer survivors. Keywords: prostate cancer volumetric modulated arc therapy erectile dysfunction penile bulb dosimetric predictors SHIM score radiation therapy

1 November 2025 in Innovations & Thérapeutiques en Oncologie
Verified
Journal Article
Closed access
PDF file
RLRachida Laraichi
Rachida Laraichi
SSSara Smiti
Sara Smiti
CEChadia Ezzouitina
Chadia Ezzouitina
FCFatima Zahra Chraa
Fatima Zahra Chraa
ISIhsane SKITIOUI
Ihsane SKITIOUI
KHKhalid Hassouni
Khalid Hassouni